{"id":"CHEMBL1078534","canonicalSmiles":"C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12","inchiKey":"LUJVUUWNAPIQQI-QAGGRKNESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ANDROSTENEDONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["93576728"],"drugbank":["DB07373"],"chEBI":["40799"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL114283","canonicalSmiles":"Nc1ccc2c(c1)CN1C(=O)c3ccccc3C1=N2","inchiKey":"SRIOCKJKFXAKHK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DANIQUIDONE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAY H 2049","BAY-H-2049","Batracylin","Daniquidone","NSC-320846"],"crossReferences":{"PubChem":["170466457","457170"],"drugbank":["DB12804"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1177","canonicalSmiles":"NC1=NC(=O)C(c2ccccc2)O1","inchiKey":"NRNCYVBFPDDJNE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PEMOLINE","yearOfFirstApproval":1975,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Canada"," United Kingdom"],"classes":["Hepatotoxicity"],"year":1997},"tradeNames":["Cylert","Pemoline","Ronyl","Tradon","Volital"],"synonyms":["Azoksodon","Azoxodon","Azoxodone","Centramin","Dantromin","Deltamin","Deltamine","Fenoxazol","Hyton","Hyton asa","Kethamed","LA-956","NSC-169499","NSC-25159","Nitan","Okodon","Pemolin","Pemoline","Pheniminooxazolidinone","Phenoxazole","Phenylisohydantoin","Phenylpseudohydantoin","Pioxol","Pondex","Sigmadyn","Sistra","Stimul","Stimulol","Tradone","YH-1"],"crossReferences":{"PubChem":["144206062","170465421","26719702"],"TG-GATEs":["51"],"Wikipedia":["Pemoline"],"drugbank":["DB01230"],"chEBI":["7953"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1975 and is indicated for attention deficit hyperactivity disorder and has 1 investigational indication. It was withdrawn in Canada and  United Kingdom initially in 1997 due to Hepatotoxicity. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200430","canonicalSmiles":"CC(=O)Oc1ccc2c(c1)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12","inchiKey":"FHXBMXJMKMWVRG-SLHNCBLASA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ESTRADIOL ACETATE","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Femring","Femtrace"],"synonyms":["E3A","ESTRADIOL-3-ACETATE","Estradiol 3-acetate","Estradiol acetate"],"crossReferences":{"DailyMed":["estradiol%20acetate"],"PubChem":["144204912","170465258"],"drugbank":["DB13952"]},"linkedTargets":{"rows":["ENSG00000091831"],"count":1},"linkedDiseases":{"rows":["EFO_1000096","EFO_0003922"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2003 and is indicated for atrophy and menopause. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200733","canonicalSmiles":"FC(F)OC(F)C(F)(F)F","inchiKey":"DPYMFVXJLLWWEU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DESFLURANE","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Suprane"],"synonyms":["Desflurane","I-653"],"crossReferences":{"DailyMed":["desflurane"],"Wikipedia":["Desflurane"],"drugbank":["DB01189"],"chEBI":["4445"]},"linkedTargets":{"rows":["ENSG00000169427","ENSG00000109158","ENSG00000145863","ENSG00000082482","ENSG00000187730","ENSG00000011677","ENSG00000151834","ENSG00000145864","ENSG00000166206","ENSG00000022355","ENSG00000182256","ENSG00000102287","ENSG00000186795","ENSG00000171303","ENSG00000094755","ENSG00000145888","ENSG00000268089","ENSG00000163285","ENSG00000113327","ENSG00000100433","ENSG00000186297","ENSG00000163288"],"count":22},"linkedDiseases":{"rows":["MONDO_0018373","EFO_0005323","EFO_0001645","EFO_0004278","EFO_1001905","EFO_0000266","EFO_1001311","EFO_0001073","EFO_1002048","EFO_0002615","HP_0000713","EFO_0003884","EFO_0004888","MONDO_0005178","EFO_1001250"],"count":15},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1992 and has 2 investigational indications."}
{"id":"CHEMBL1201075","canonicalSmiles":"CC(=O)N(CC(O)CO)c1c(I)c(C(=O)NCCO)c(I)c(C(=O)NCC(O)CO)c1I","inchiKey":"UUMLTINZBQPNGF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IOXILAN","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Oxilan","Oxilan-300","Oxilan-350"],"synonyms":["Ioxilan","Ioxitol","Loxilan","NSC-760056"],"crossReferences":{"PubChem":["144206678","170465160"],"Wikipedia":["Ioxilan"],"drugbank":["DB09135"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1995."}
{"id":"CHEMBL1201314","canonicalSmiles":"CC(C)[C@H](N)C(=O)OCC(CO)OCn1cnc2c(=O)[nH]c(N)nc21","inchiKey":"WPVFJKSGQUFQAP-GKAPJAKFSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"VALGANCICLOVIR","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Valganciclovir"],"crossReferences":{"DailyMed":["valganciclovir%20hydrochloride"],"Wikipedia":["Valganciclovir"],"drugbank":["DB01610"],"chEBI":["63635"]},"childChemblIds":["CHEMBL1200454"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and has 4 approved and 14 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201535","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENYLPROPANOLAMINE POLISTIREX","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL61006","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"classes":["Neurotoxicity"],"year":2002},"tradeNames":[],"synonyms":["Phenylpropanolamine polistirex"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1984. It was withdrawn in United States  in 2002 due to Neurotoxicity."}
{"id":"CHEMBL1213528","canonicalSmiles":"C/C=C/C(=O)O","inchiKey":"LDHQCZJRKDOVOX-NSCUHMNNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CROTONIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Crotonate","Crotonic Acid"],"crossReferences":{"Wikipedia":["Crotonic_acid"],"drugbank":["DB02074"],"chEBI":["41131"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1229517","canonicalSmiles":"CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F","inchiKey":"GPXBXXGIAQBQNI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VEMURAFENIB","yearOfFirstApproval":2011,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Zelboraf"],"synonyms":["PLX-4032","PLX4032","RG 7204","RG-7204","RO 5185426","RO-51-85426","RO-5185426","Vemurafenib"],"crossReferences":{"DailyMed":["vemurafenib"],"Wikipedia":["Vemurafenib"],"drugbank":["DB08881"],"chEBI":["63637"]},"linkedTargets":{"rows":["ENSG00000157764"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0002618","EFO_0000365","MONDO_0002108","EFO_0000756","EFO_1000209","EFO_0000222","EFO_0003060","EFO_1001951","EFO_0000311","EFO_1000489","EFO_1001480","EFO_1000318","EFO_1000956","EFO_0002892","EFO_0000389","MONDO_0002898","EFO_0009259","EFO_0000574","EFO_0000326","EFO_0001378","HP_0100727","MONDO_0024880","EFO_0002617"],"count":24},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2011 and has 5 approved and 15 investigational indications."}
{"id":"CHEMBL1229908","canonicalSmiles":"CCN(CC)C(=O)c1ccc(O)c(OC)c1","inchiKey":"BQJODPIMMWWMFC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHAMIVAN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Clairvan","Vandid"],"synonyms":["Emivan","Etamivan","Ethamivan","NSC-406087"],"crossReferences":{"PubChem":["11111131","144203686","144203687","170466295","50104185","56422402","85231028","855940","90340666"],"drugbank":["DB08989"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for respiratory system disease."}
{"id":"CHEMBL12315","canonicalSmiles":"c1ccc2cnccc2c1","inchiKey":"AWJUIBRHMBBTKR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISOQUINOLINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Benzanine"],"crossReferences":{"PubChem":["144212820"],"Wikipedia":["Isoquinoline"],"drugbank":["DB04329"],"chEBI":["16092"]},"childChemblIds":["CHEMBL328754"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232399","canonicalSmiles":"COC(=O)C1CCN(C(=O)c2ccc(NCc3cnc4nc(N)nc(N)c4n3)cc2)CC1","inchiKey":"NYNAFINLHQEHKU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1232399","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07689"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232595","canonicalSmiles":"C=Cc1ccc(O)c(OC)c1","inchiKey":"YOMSJEATGXXYPX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1232595","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["251919945"],"drugbank":["DB03514"],"chEBI":["42438"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232731","canonicalSmiles":"NC(C(=O)O)C(=O)O","inchiKey":"JINBYESILADKFW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1232731","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02289"],"chEBI":["17475"]},"childChemblIds":["CHEMBL3360545"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234635","canonicalSmiles":"CCOc1ccc2ccccc2c1C(=O)NCB(O)O","inchiKey":"VGXJNGVFESCMME-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234635","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02841"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1237065","canonicalSmiles":"COc1cccc(C2(O)CCCCC2CN(C)C)c1.Cl","inchiKey":"PPKXEPBICJTCRU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TRAMADOL HYDROCHLORIDE","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1237044","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aceon","Conzip","Dromadol sr","Dromadol xl","Invodol sr","Larapam sr","Mabron","Maneo","Marol","Maxitram sr","Nobligan ret","Oldaram","Qdolo","Rybix odt","Ryzolt","Tilodol sr","Tradorec xl","Tramacet","Tramadol hydrochloride","Tramake","Tramake insts","Tramquel sr","Tramulief sr","Ultram","Ultram er","Zamadol","Zamadol 24hr","Zamadol melt","Zamadol sr","Zeridame sr","Zydol","Zydol sr","Zydol xl"],"synonyms":["Amadol","CG-315","CG-315E","Contramal","NIH-10969","NSC-759105","Tradonal","Tramadol hcl","Tramadol hydrochloride","Tramadol hydrochloride civ","Tramal","U-26,225A","U-26225A","Zamudol","Zertane"],"crossReferences":{"DailyMed":["tramadol%20hydrochloride"]},"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["EFO_1000783","EFO_0003890","HP_0012532","EFO_0004253","EFO_0010072","HP_0003419","MONDO_0002258","EFO_0003843","MONDO_0005178","EFO_0000311"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1995 and has 3 approved and 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1305","canonicalSmiles":"c1ccc(CN(CC2=NCCN2)c2ccccc2)cc1","inchiKey":"REYFJDPCWQRWAA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ANTAZOLINE","yearOfFirstApproval":1994,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Antaz sulf","Vasocon-a"],"synonyms":["Antazoline","Atazoline","Vasocon-A"],"crossReferences":{"PubChem":["11112519","11113348","124882433","50100471","50100472"],"Wikipedia":["Antazoline"],"drugbank":["DB08799"],"chEBI":["84115"]},"childChemblIds":["CHEMBL1256819","CHEMBL1200550"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["MP_0001845","EFO_0000275","EFO_0000678","MONDO_0005271","HP_0001742"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1994 and is indicated for nasal congestion and allergic disease and has 2 investigational indications."}
{"id":"CHEMBL131890","canonicalSmiles":"Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(O)(O)=S)[C@@H](O)[C@H]1O","inchiKey":"NLTUCYMLOPLUHL-KQYNXXCUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ATPGAMMAS","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ATP-gammaS","Atpgammas"],"crossReferences":{"drugbank":["DB02930"],"chEBI":["27575"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1325592","canonicalSmiles":"C=CC1=C(C)c2cc3[nH]c(cc4nc(cc5[nH]c(cc1n2)c(C)c5CCC(=O)O)C(CCC(=O)O)=C4C)c(C)c3C=C","inchiKey":"KSFOVUSSGSKXFI-UJJXFSCMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROTOPORPHYRIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-2632","Protoporphyrin ix"],"crossReferences":{"PubChem":["11111672","124881200","26747639","29218041","50106857","85231196","90341512"],"drugbank":["DB02285"],"chEBI":["15430"]},"childChemblIds":["CHEMBL2105866"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL133097","canonicalSmiles":"COC(=O)N[C@]1(C(N)=O)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O","inchiKey":"ZQTAMPRAONLFQI-FMTWGGRWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL133097","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04013"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1335656","canonicalSmiles":"CC(=O)N=c1sc(S(N)(=O)=O)nn1C","inchiKey":"FLOSMHQXBMRNHR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1335656","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144204015"],"drugbank":["DB00703"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1339216","canonicalSmiles":"O=C(Oc1ccccc1)c1ccccc1O","inchiKey":"ZQBAKBUEJOMQEX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENYL SALICYLATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FEMA NO. 3960","NSC-33406","Phenyl Salicylate","Phenyl salicylate","Salol"],"crossReferences":{"PubChem":["144207008","144209009","144213266","170465501","17389589","26753033"],"Wikipedia":["Phenyl_salicylate"],"drugbank":["DB11071"],"chEBI":["34918"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL148630","canonicalSmiles":"O=Cc1ccccc1OP(=O)(O)OCc1ccccc1","inchiKey":"PWDTUFYQEUEVQD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Phosphoric Acid Benzyl Ester 2-Formyl-Phenyl Ester","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Phosphoric Acid Benzyl Ester 2-Formyl-Phenyl Ester"],"crossReferences":{"drugbank":["DB03078"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL152452","canonicalSmiles":"CC(=O)N[C@@H]1[C@@H](O)C[C@](O)(C(=O)O)O[C@H]1[C@@H](O)[C@@H](O)CO","inchiKey":"SQVRNKJHWKZAKO-USOVHJGOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SIALIC ACID","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aceneuramic acid","N-acetylneuraminic acid","NSC-111756","Sialic acid","Sialic acids n-acetylneuraminic acid","UX-001","UX001"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1616","canonicalSmiles":"CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3.Cl","inchiKey":"SKYZYDSNJIOXRL-BTQNPOSSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"APOMORPHINE HYDROCHLORIDE","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL53","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Apo-go","Apo-go pen","Apo-go pfs","Apokyn","Apomorph hcl","Britaject","Bromophin","Dacepton","Diagesil","Diamorph hcl","Diamorph roche","Diamorph,cocaine,chlorpromazine","Diaphine","Euphorin","Kynmobi","Uprima"],"synonyms":["Apokinon","Apomine","Apomorphine HCl","Apomorphine hcl","Apomorphine hydrochloride","Apomorphine hydrochloride hemihydrate","Apomorphine hydrochloride hydrate","Apomorphinum muriaticum","Diamorphine hydrochloride ","Ixense","Kw-6500","NSC-11442","NSC-755875","Taluvian"],"crossReferences":{"DailyMed":["apomorphine%20hydrochloride"]},"linkedTargets":{"rows":["ENSG00000149295","ENSG00000069696","ENSG00000151577"],"count":3},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0005180","EFO_0003882"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and is indicated for parkinson disease and has 2 investigational indications."}
{"id":"CHEMBL1620875","canonicalSmiles":"CCN(CC)CCc1nc(-c2ccccc2)no1","inchiKey":"IDCHQQSVJAAUQQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXOLAMINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AF-438 FREE BASE","AF-438 [AS CITRATE]","Oksalamin","Oxolamine","SKF 9976 FREE BASE","SKF 9976 [AS CITRATE]","SKF-9976 FREE BASE"],"crossReferences":{"Wikipedia":["Oxolamine"],"drugbank":["DB13216"]},"childChemblIds":["CHEMBL1448044"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL1642","canonicalSmiles":"CS(=O)(=O)O.Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1","inchiKey":"YLMAHDNUQAMNNX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IMATINIB MESYLATE","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL941","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Gleevec","Glivec","Imatinib mesylate"],"synonyms":["Gleevec","Imatinib (as mesilate)","Imatinib accord","Imatinib medac","Imatinib mesilate","Imatinib mesylate","Imatinib methane sulfonate","Imatinib methanesulfonate","NSC-716051","QTI-571","QTI571","Qti571","STI 571","STI-571","STI571"],"crossReferences":{"DailyMed":["imatinib%20mesylate"],"PubChem":["144205237","170465393","49681833"],"chEBI":["31690"]},"linkedTargets":{"rows":["ENSG00000097007","ENSG00000186716","ENSG00000157404","ENSG00000113721"],"count":4},"linkedDiseases":{"rows":["MONDO_0000873","EFO_0001361","EFO_0004683","EFO_0000756","MONDO_0000956","EFO_1000657","EFO_0005952","EFO_0000333","EFO_1001951","EFO_0000565","EFO_0000339","EFO_0000588","EFO_0000389","MONDO_0008903","EFO_1001814","EFO_0000094","EFO_0000760","MONDO_0002715","EFO_0002618","MONDO_0013730","MONDO_0005149","EFO_0000220","MONDO_0002108","MONDO_0008170","EFO_0009907","Orphanet_636","EFO_1001946","EFO_0002429","MONDO_0008315","Orphanet_398934","MONDO_0044917","EFO_0002428","EFO_0000574","MONDO_0004979","EFO_1000613","EFO_0001376","Orphanet_232","MONDO_0015686","EFO_0000768","EFO_1001465","MONDO_0007254","EFO_0000209","MONDO_0021063","MONDO_0002087","MONDO_0003541","Orphanet_538","HP_0001880","EFO_0002430","MONDO_0001056","MONDO_0002158","Orphanet_31112","EFO_0004289","EFO_0000673","EFO_1001361","EFO_1001993","MONDO_0020743","EFO_0000717","MONDO_0002618","EFO_1000158","EFO_0002914","EFO_0000616","EFO_0006859","EFO_0000503","Orphanet_44890","MONDO_0016586","EFO_0000222","EFO_0000313","MONDO_0000870","EFO_0004198","MONDO_0003865","EFO_0003060","EFO_0000311","EFO_1001471","EFO_0000658","MONDO_0005301","EFO_0006861","MONDO_0005147","MONDO_0011962","EFO_0000702","EFO_1001947","MONDO_0002367","EFO_1001467","MONDO_0024880","EFO_0000691","EFO_0000519","Orphanet_31837"],"count":86},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and is indicated for chronic myelogenous leukemia and has 74 investigational indications."}
{"id":"CHEMBL1722209","canonicalSmiles":"Cc1ccc(O)c([C@H](CCN(C(C)C)C(C)C)c2ccccc2)c1.O=C(O)C(O)C(O)C(=O)O","inchiKey":"TWHNMSJGYKMTRB-VEIFNGETSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TOLTERODINE TARTRATE","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1382","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Detrol","Detrol la","Tolterodine tartrate"],"synonyms":["PNU-200583E","Tolterodine l-tartrate","Tolterodine tartrate"],"crossReferences":{"DailyMed":["tolterodine%20tartrate"],"PubChem":["49681822"]},"linkedTargets":{"rows":["ENSG00000133019","ENSG00000181072"],"count":2},"linkedDiseases":{"rows":["EFO_0006865","EFO_1000781"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and is indicated for urgency urinary incontinence and overactive bladder."}
{"id":"CHEMBL1743001","drugType":"Antibody","blackBoxWarning":false,"name":"CIXUTUMUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cixutumumab","IMC-A12","NSC-742460"],"linkedTargets":{"rows":["ENSG00000140443"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0002618","EFO_0006859","EFO_0000637","EFO_0000437","EFO_0000248","EFO_0000571","EFO_0000756","EFO_1000657","MONDO_0007254","EFO_1001968","MONDO_0021063","MONDO_0021038","EFO_0000305","EFO_0003060","MONDO_0008315","EFO_1001951","EFO_0000311","EFO_0000588","EFO_0006861","MONDO_0008903","EFO_0000182","EFO_0000673","EFO_0000702","EFO_1000796","EFO_0003050","EFO_0000181"],"count":27},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 26 investigational indications."}
{"id":"CHEMBL1743072","drugType":"Antibody","blackBoxWarning":false,"name":"SOLANEZUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-2062430","LY2062430","Solanezumab"],"linkedTargets":{"rows":["ENSG00000142192"],"count":1},"linkedDiseases":{"rows":["HP_0100543","MONDO_0004975"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1743077","drugType":"Antibody","blackBoxWarning":false,"name":"TENATUMOMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ST-2146","Tenatumomab"],"linkedTargets":{"rows":["ENSG00000041982"],"count":1},"linkedDiseases":{"rows":["MONDO_0044334","EFO_0003863","EFO_0003869","EFO_0003860","EFO_0004284","EFO_0004198","EFO_0005952","EFO_0003853"],"count":8},"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL187460","canonicalSmiles":"C[C@H]1COC2=C1C(=O)C(=O)c1c2ccc2c1CCCC2(C)C","inchiKey":"GVKKJJOMQCNPGB-JTQLQIEISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CRYPTOTANSHINONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cryptotanshinone"],"crossReferences":{"PubChem":["24824127","26757029","521176"],"drugbank":["DB15579"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1950651","canonicalSmiles":"COC(=O)N1CCC(CC#Cc2nc(N)c3ncn([C@@H]4O[C@H](C(=O)NC5CC5)[C@@H](O)[C@H]4O)c3n2)CC1","inchiKey":"SQJXTUJMBYVDBB-RQXXJAGISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EVODENOSON","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Atl313, de-112"],"synonyms":["ATL-313","ATL313","Atl313","DE-112","Evodenoson"],"crossReferences":{"drugbank":["DB12295"]},"linkedTargets":{"rows":["ENSG00000128271"],"count":1},"linkedDiseases":{"rows":["EFO_0004190","EFO_1001069"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2022968","canonicalSmiles":"CN1CCN(Cc2ccc(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)N(C)C)n3)cc2)CC1","inchiKey":"YUAALFPUEOYPNX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DUBERMATINIB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dubermatinib","HCl-2084","TP-0903","TP0903","Tp 0903","Tp-0903"],"crossReferences":{"drugbank":["DB15187"]},"childChemblIds":["CHEMBL4594281"],"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL207456","canonicalSmiles":"[11CH3]Nc1ccc(-c2nc3ccc(O)cc3s2)cc1","inchiKey":"ZQAQXZBSGZUUNL-BJUDXGSMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PITTSBURGH COMPOUND B","maximumClinicalTrialPhase":0,"parentId":"CHEMBL93124","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(11c)pib","PIB C-11","Pittsburgh compound b","Pittsburgh compound b c-11"],"crossReferences":{"drugbank":["DB15161"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2096656","drugType":"Small molecule","blackBoxWarning":false,"name":"TECHNETIUM TC 99M PENTETATE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL2110551","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["An-dtpa","Draximage dtpa","Dtpa","Mpi dtpa kit - chelate","Tc 99m dtpa kit (chelate)","Techneplex","Technetium tc-99m pentetate kit"],"synonyms":["Human serum albumin diethylenetriaminepentaacetic acid technetium (99mtc) injection","Technetium (99mtc) pentetic acid","Technetium tc 99m pentetate","Technetium tc 99m pentetate sodium","Technetium tc-99m pentetate","Technetium tc-99m pentetate kit"],"crossReferences":{"DailyMed":["technetium%20tc-99m%20pentetate%20kit"],"DrugCentral":["5096"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL2103826","canonicalSmiles":"CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@@H](N)CC(N)=O)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)O","inchiKey":"DWLTUUXCVGVRAV-XWRHUKJGSA-N","drugType":"Protein","blackBoxWarning":false,"name":"DAVUNETIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AL-108","AL-208","Davunetide"],"crossReferences":{"drugbank":["DB12613"]},"linkedTargets":{"rows":["ENSG00000261456","ENSG00000167553","ENSG00000127824","ENSG00000188229","ENSG00000198033","ENSG00000258947","ENSG00000152086","ENSG00000196230","ENSG00000104833","ENSG00000137267","ENSG00000167552","ENSG00000101162","ENSG00000137285","ENSG00000123416","ENSG00000176014"],"count":15},"linkedDiseases":{"rows":["MONDO_0005090","HP_0100543","Orphanet_683"],"count":3},"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2104266","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)C3=CCC=CC3)C(=O)N2[C@H]1C(=O)O","inchiKey":"RPBAFSBGYDKNRG-NJBDSQKTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EPICILLIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Dexacillin"],"synonyms":["Epicillin","SQ 11,302","SQ-11302"],"crossReferences":{"drugbank":["DB13300"],"chEBI":["58974"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2104856","canonicalSmiles":"Cc1cc(-n2c(=O)[nH]c(=O)n(C)c2=O)ccc1Oc1ccc(S(=O)(=O)C(F)(F)F)cc1","inchiKey":"VBUNOIXRZNJNAD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PONAZURIL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ponazuril","Toltrazuril sulfone"],"crossReferences":{"PubChem":["144206941"],"drugbank":["DB11452"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105148","canonicalSmiles":"CC1(CCN2CCCCC2)C(=O)CCc2ccccc21","inchiKey":"RVXGRCNWGOHSDE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NEPINALONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nepinalone"],"crossReferences":{"drugbank":["DB13445"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2105467","canonicalSmiles":"Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)/C2=C\\F)c(=O)n1","inchiKey":"GFFXZLZWLOBBLO-ASKVSEFXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TEZACITABINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FMD-C","KW-2331","MDL-101731"],"crossReferences":{"drugbank":["DB06433"]},"childChemblIds":["CHEMBL3989496"],"linkedTargets":{"rows":["ENSG00000048392","ENSG00000167325","ENSG00000171848"],"count":3},"linkedDiseases":{"rows":["EFO_0003897","EFO_0002916","EFO_0004142","EFO_0000228","EFO_0000311"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2105527","canonicalSmiles":"CN1C(=O)CN=C(C2=CCCCC2)c2cc(Cl)ccc21","inchiKey":"IQWYAQCHYZHJOS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TETRAZEPAM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["European Union"],"year":2013},"tradeNames":[],"synonyms":["CB 4261","CB-4261","Myolastan","Tetrazepam"],"crossReferences":{"drugbank":["DB13324"]},"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in European Union  in 2013."}
{"id":"CHEMBL2106224","canonicalSmiles":"Nc1nnnn1-c1ccccc1","inchiKey":"ULIDRMKBVYYVIQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FENAMOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AL 0559","AL-0559","Fenamole","NSC-25413","P-463","PAT"],"crossReferences":{"PubChem":["170466193"],"drugbank":["DB12506"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2106905","canonicalSmiles":"CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3C[C@@H](C[131I])C4=C(CC[C@H](O)C4)[C@H]3CC[C@@]21C","inchiKey":"QJHZPCLORSPENH-DRTKWHMQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NORCHOLESTENOL IODOMETHYL (131I) [INJECTION]","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2110976","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Norcholestenol iodomethyl (131i) [injection]"],"crossReferences":{"drugbank":["DB13487"],"chEBI":["34893"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107882","drugType":"Unknown","blackBoxWarning":false,"name":"RELAXIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Cervilaxin","Releasin"],"synonyms":["Pig relaxin","Porcine relaxin","Relaxin","Relaxin (swine)","Relaxin porcine","Relaxin sus scrofa"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2108670","drugType":"Antibody","blackBoxWarning":false,"name":"BEZLOTOXUMAB","yearOfFirstApproval":2016,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mdx-1388","Zinplava"],"synonyms":["Bezlotoxumab","MBL-CDB1","MDX-1388","MK-6072","Mk-6072"],"crossReferences":{"DailyMed":["bezlotoxumab"],"DrugCentral":["5186"]},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2016 and is indicated for commensal clostridium infectious disease and clostridium difficile infection."}
{"id":"CHEMBL2108744","drugType":"Unknown","blackBoxWarning":false,"name":"SODIUM ALGINATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Algin","Alginic acid, sodium salt","E-401","FEMA NO. 2014","Hydagen 558 p","INS NO.401","INS-401","Polyelectrolyte 211","Sodium alginate","Sodium alginate 2200-3000"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2109201","drugType":"Unknown","blackBoxWarning":false,"name":"MUMPS VIRUS VACCINE LIVE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Mumpsvax"],"synonyms":["Mumps vaccine","Mumps vaccine (live attenuated)","Mumps virus live antigen, a","Mumps virus vaccine live","Mumps virus vaccine,live","Mumps, live attenuated"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2109256","drugType":"Antibody","blackBoxWarning":false,"name":"SGN-30","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SGN-30","Sgn-30"],"linkedTargets":{"rows":["ENSG00000120949"],"count":1},"linkedDiseases":{"rows":["EFO_0004708","EFO_0003032","EFO_0000558","EFO_0001642","EFO_0002913","EFO_0000574","EFO_0000183"],"count":7},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL2109337","drugType":"Antibody","blackBoxWarning":false,"name":"MDX-1342","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MDX-1342","Mdx-1342"],"linkedTargets":{"rows":["ENSG00000177455"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","EFO_0000095"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2109427","drugType":"Antibody","blackBoxWarning":false,"name":"ZOLBETUXIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Claudiximab","IMAB-362","IMAB362","Zolbetuximab"],"linkedTargets":{"rows":["ENSG00000066405"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_1000044"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2109484","drugType":"Antibody","blackBoxWarning":false,"name":"BB-10901","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BB-10901","HUN901-DM1"],"linkedTargets":{"rows":["ENSG00000149294"],"count":1},"linkedDiseases":{"rows":["EFO_0000702","EFO_0001378"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2110571","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM PERTECHNETATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":[],"crossReferences":{"DailyMed":["technetium%20tc-99m%20sodium%20pertechnetate%20generator"]},"childChemblIds":["CHEMBL2096641"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL216913","canonicalSmiles":"CC(/C=N/N=C(N)N)=N\\N=C(N)N","inchiKey":"MXWHMTNPTTVWDM-NXOFHUPFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MITOGUAZONE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mitoguazone"],"crossReferences":{"drugbank":["DB12967"],"chEBI":["43996"]},"childChemblIds":["CHEMBL1995011"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL218291","canonicalSmiles":"O=c1[nH]cnc2c([C@@H]3N[C@H](CO)[C@@H](O)[C@H]3O)c[nH]c12","inchiKey":"IWKXDMQDITUYRK-KUBHLMPHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FORODESINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Fodosine"],"synonyms":["BCX-1777","Forodesine","NSC-717904"],"crossReferences":{"Wikipedia":["Forodesine"],"drugbank":["DB06185"],"chEBI":["43362"]},"childChemblIds":["CHEMBL550755","CHEMBL1213652"],"linkedTargets":{"rows":["ENSG00000198805"],"count":1},"linkedDiseases":{"rows":["EFO_0000565","EFO_0000095","EFO_0004289","EFO_0002913","EFO_0000574","EFO_0000094","EFO_0000311","MONDO_0000430"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL24924","canonicalSmiles":"O=C1c2ccccc2C(=O)C1c1ccc(F)cc1","inchiKey":"NASXCEITKQITLD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUINDIONE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Previscan"],"synonyms":["Fluindione","Previsccan"],"crossReferences":{"PubChem":["144205432","29216219"],"drugbank":["DB13136"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for recurrent thrombophlebitis."}
{"id":"CHEMBL269521","canonicalSmiles":"Clc1cncc(N2CCNCC2)n1","inchiKey":"CJAWPFJGFFNXQI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MK-212","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-212"],"crossReferences":{"PubChem":["11113807","26751984"],"drugbank":["DB12111"]},"childChemblIds":["CHEMBL3250751"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL280051","canonicalSmiles":"CCCCc1nc2c(=O)[nH][nH]c(=O)c2[nH]1","inchiKey":"DQHJYYALMHIEAH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL280051","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02441"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL292376","canonicalSmiles":"COc1cccc([C@@H](C)NCCCc2ccccc2Cl)c1","inchiKey":"ZVQUCWXZCKWZBP-CQSZACIVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TECALCET","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tecalcet"],"childChemblIds":["CHEMBL2107572"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL297884","canonicalSmiles":"COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)C[C@H]5/C=C\\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(C)C)n3)nc2c1","inchiKey":"PJZPDFUUXKKDNB-KNINVFKUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CILUPREVIR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BILN 2061 ZW","BILN-2061","BILN-2061-ZW","Ciluprevir"],"crossReferences":{"Wikipedia":["Ciluprevir"],"drugbank":["DB05868"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL3112741","canonicalSmiles":"O=C(NC1CCNCC1)[C@@H]1CC[C@@H]2CN1C(=O)N2OS(=O)(=O)O","inchiKey":"SMOBCLHAZXOKDQ-ZJUUUORDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RELEBACTAM","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":[],"crossReferences":{"DailyMed":["relebactam"],"drugbank":["DB12377"]},"childChemblIds":["CHEMBL3301605","CHEMBL4516632"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and has 3 approved and 4 investigational indications."}
{"id":"CHEMBL3137322","canonicalSmiles":"O[C@H]([C@@H]1CO1)[C@@H](O)[C@H]1CO1","inchiKey":"AAFJXZWCNVJTMK-GUCUJZIJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIANHYDROGALACTITOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1,2:5,6-dianhdrogalactitol","1,2:5,6-dianhydrogalactitol","Dianhydrogalactitol","Dulcitol diepoxide","NSC-132313","NSC-1323313","VAL-083"],"crossReferences":{"drugbank":["DB12873"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3137332","canonicalSmiles":"Cc1c(CC(=O)O)c2cccnc2n1Cc1ccc(S(C)(=O)=O)cc1C(F)(F)F","inchiKey":"GFPPXZDRVCSVNR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FEVIPIPRANT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fevipiprant","NVP-QAW039","QAW-039","QAW039"],"crossReferences":{"drugbank":["DB12011"]},"linkedTargets":{"rows":["ENSG00000183134"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","HP_0000083","EFO_1000391","EFO_0001421","MONDO_0004979","EFO_0000341","EFO_0000274","HP_0001880"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL3301603","canonicalSmiles":"CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1.CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1.O=C(O)/C=C/C(=O)O","inchiKey":"UJOUWHLYTQFUCU-WXXKFALUSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"GILTERITINIB FUMARATE","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3301622","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Xospata"],"synonyms":["ASP-2215 HEMIFUMARATE","ASP2215 hemifumarate","Gilteritinib fumarate","Gilteritinib hemifumarate"],"crossReferences":{"DailyMed":["gilteritinib%20fumarate"]},"linkedTargets":{"rows":["ENSG00000167601","ENSG00000122025"],"count":2},"linkedDiseases":{"rows":["EFO_0000222","MONDO_0004643"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for myeloid leukemia and acute myeloid leukemia. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3301614","canonicalSmiles":"Cc1cc(C)c2nc(-c3cnc(NCCCC4CCN(C)CC4)nc3C)[nH]c2c1.Cc1cc(C)c2nc(-c3cnc(NCCCC4CCN(C)CC4)nc3C)[nH]c2c1.O=C(O)C(O)C(O)C(=O)O","inchiKey":"FWIDBLDKHORZBP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TOREFORANT TARTRATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL3301609","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["JNJ-38518168","JNJ-38518168 HEMITARTRATE","Toreforant tartrate"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL3301673","canonicalSmiles":"CCCCCNC(=O)c1coc([C@@H]2[C@H]3CC[C@H](O3)[C@@H]2Cc2ccccc2CCC(=O)O)n1","inchiKey":"BBPRUNPUJIUXSE-DXKRWKNPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IFETROBAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-180291","Ifetroban"],"crossReferences":{"drugbank":["DB12321"]},"childChemblIds":["CHEMBL3301674"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL3330226","canonicalSmiles":"O=c1nc(N2CCN(CC3CCCCC3)CC2)sc2c([N+](=O)[O-])cc(C(F)(F)F)cc12","inchiKey":"BJDZBXGJNBMCAV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MACOZINONE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Macozinone","PBTZ-169","PBTZ169"],"crossReferences":{"drugbank":["DB14821"]},"childChemblIds":["CHEMBL4521338"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL346235","canonicalSmiles":"CCN(CC)CCOc1ccc2nc(N(C)C)sc2c1.Cl.Cl","inchiKey":"FZNXAQMQVKBXDR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIAMTHAZOLE DIHYDROCHLORIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL1184360","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["France"," United States"],"classes":["Neurotoxicity"," Psychiatric toxicity"],"year":1972},"tradeNames":[],"synonyms":["Atelor","Diamthazole dihydrochloride","Diamthazole hydrochloride","Dimazole dihydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in France and  United States initially in 1972 due to Neurotoxicity and  Psychiatric toxicity."}
{"id":"CHEMBL3527416","canonicalSmiles":"C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(-c4ccc(O)c(O)c4)oc4cc(OCCO)cc(O)c4c3=O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O","inchiKey":"MBHXKZDTQCSVPM-BDAFLREQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MONOXERUTIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(beta-hydroxyethyl)rutoside, o-","Monoxerutin"],"crossReferences":{"drugbank":["DB13764"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545175","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-03882845","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-3882845","Pf-03882845"],"linkedTargets":{"rows":["ENSG00000151623"],"count":1},"linkedDiseases":{"rows":["EFO_0000401","MONDO_0005148"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545189","drugType":"Antibody","blackBoxWarning":false,"name":"LANADELUMAB","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Takhzyro"],"synonyms":["DX-2930","Lanadelumab","Lanadelumab (shp643)","Lanadelumab-flyo","SHP-643","Tak-743"],"crossReferences":{"DailyMed":["lanadelumab%20(shp643)"]},"linkedTargets":{"rows":["ENSG00000164344"],"count":1},"linkedDiseases":{"rows":["EFO_0000546","MONDO_0100096","EFO_0005532","Orphanet_91378"],"count":4},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for hereditary angioedema and has 3 investigational indications."}
{"id":"CHEMBL3546271","canonicalSmiles":"Fc1ccc(-c2ccc3c(c2)[nH]c2ccncc23)cn1","inchiKey":"GETAAWDSFUCLBS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLORTAUCIPIR","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Flortaucipir","T-807","T807"],"crossReferences":{"DailyMed":["flortaucipir%20f-18"],"drugbank":["DB15033"]},"childChemblIds":["CHEMBL3545253"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and has 3 approved and 1 investigational indication."}
{"id":"CHEMBL370143","canonicalSmiles":"NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O","inchiKey":"UOZODPSAJZTQNH-LSWIJEOBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PAROMOMYCIN","yearOfFirstApproval":1969,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["ANTIBIOTIC 503-3","ANTIBIOTIC SF 767B","ANTIBIOTIC SF-767B","Aminosidin","Aminosidine","Catenulin","Crestomycin","Estomycin","Gabromycin","Hydroxymycin","Monomycin","Monomycin a","Neomycin e","Paromomycin","Paromomycin i","Paucimycin","Quintomycin c","R 400","R-400"],"crossReferences":{"DailyMed":["paromomycin%20sulfate"],"Wikipedia":["Paromomycin"],"drugbank":["DB01421"],"chEBI":["7934"]},"childChemblIds":["CHEMBL2206196"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1969 and is indicated for infection and amebiasis and has 5 investigational indications."}
{"id":"CHEMBL3707183","canonicalSmiles":"C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12.C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12.O.O.O=S(=O)(O)O","inchiKey":"ZHNFLHYOFXQIOW-AHSOWCEXSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"QUINIDINE SULFATE","yearOfFirstApproval":1962,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1294","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cin-quin","Quinicardine","Quinidex","Quinidine sulfate","Quinora"],"synonyms":["AVP-786 COMPONENT QUINIDINE SULFATE","NSC-10004","QUINIDINE SULFATE COMPONENT OF AVP-786","Quinidex extentabs","Quinidine sulfate","Quinidine sulfate anhydrous","Quinidine sulfate dihydrate","Quinidine sulfate hydrate","Quinidine sulphate","Quinidine sulphate anhydrous","Quinidine sulphate dihydrate","Quinidine, sulfate (2:1) (salt)","Quinidini sulfas"],"crossReferences":{"DailyMed":["quinidine%20sulfate"]},"linkedTargets":{"rows":["ENSG00000185313","ENSG00000196876","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000136531","ENSG00000007314","ENSG00000153253"],"count":10},"linkedDiseases":{"rows":["MONDO_0004975","EFO_0003758","MONDO_0004976"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1962 and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3707267","canonicalSmiles":"C[C@]1([18F])C[C@@](N)(C(=O)O)C1","inchiKey":"ILMJJAKSEOUEPX-DZQYMRDVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUCICLOVINE F18","yearOfFirstApproval":2016,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3707268","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Axumin"],"synonyms":["(18f)facbc","(18f)ge-148","FACBC","Facbc f-18","Fluciclovine (18f)","Fluciclovine f 18","Fluciclovine f-18","Fluciclovine f18","GE-148","GE-148 (18F)","GE-148 F-18","NMK-36","NMK36"],"crossReferences":{"DailyMed":["fluciclovine%20f-18"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2016 and has 3 investigational indications."}
{"id":"CHEMBL371491","canonicalSmiles":"CCOCn1oc(=O)c(-c2ccc(F)cc2)c1-c1ccnc(Oc2ccccc2O)n1","inchiKey":"ZSOXFJURLPCSOO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL371491","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08395"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL372396","canonicalSmiles":"CC(C)CCO","inchiKey":"PHTQWCKDNZKARW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"3-METHYLBUTANOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144212676"],"Wikipedia":["Isoamyl_alcohol"],"drugbank":["DB02296"],"chEBI":["15837"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL37390","canonicalSmiles":"CC(O)Cn1cnc2c1c(=O)n(C)c(=O)n2C","inchiKey":"KYHQZNGJUGFTGR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROXYPHYLLINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Thean"],"synonyms":["Proxyphylline"],"crossReferences":{"PubChem":["144204022","170465953","855655"],"Wikipedia":["Proxyphylline"],"drugbank":["DB13449"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for airway obstruction."}
{"id":"CHEMBL377312","canonicalSmiles":"O=c1[nH]c2ccc(Cl)cc2c(N[C@@H]2CN3CCC2CC3)c1-c1nc2ccccc2[nH]1","inchiKey":"MOVBBVMDHIRCTG-LJQANCHMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL377312","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06852"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3833335","canonicalSmiles":"C[N+](C)(C)CC(=O)[O-].OC(O)C(Cl)(Cl)Cl","inchiKey":"ONAOIDNSINNZOA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORAL BETAINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["5107","Chloral betaine","Cloral betaine"],"crossReferences":{"drugbank":["DB01494"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL388590","canonicalSmiles":"CCc1oc2ccccc2c1C(=O)c1cc(Br)c(O)c(Br)c1","inchiKey":"WHQCHUCQKNIQEC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZBROMARONE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Desuric","Narcaricin mite"],"synonyms":["Benzbromaron","Benzbromarone","Benzpromarone","L-2214","MJ 10061","MJ-10061","NSC-85433","Uroleap"],"crossReferences":{"PubChem":["11110651","122758","144203592","170465792","24424558","26664708","4253342","50103990","56422114","855676"],"TG-GATEs":["21"],"Wikipedia":["Benzbromarone"],"drugbank":["DB12319"],"chEBI":["3023"]},"linkedTargets":{"rows":["ENSG00000197891"],"count":1},"linkedDiseases":{"rows":["Orphanet_275766","EFO_0009104","EFO_0004274","MONDO_0005148"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for gout and has 2 investigational indications."}
{"id":"CHEMBL3989926","canonicalSmiles":"COCCNCc1ccc(-c2cc3nccc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)cc4F)c3s2)nc1","inchiKey":"WLAVZAAODLTUSW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SITRAVATINIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MG-516","MG-91516","MGCD-516","MGCD516","Sitravatinib"],"crossReferences":{"drugbank":["DB15036"]},"childChemblIds":["CHEMBL4298164"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 12 investigational indications."}
{"id":"CHEMBL3990040","drugType":"Gene","blackBoxWarning":false,"name":"NALOTIMAGENE CARMALEUCEL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HSV-TK","Nalotimagene carmaleucel"],"description":"Gene drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL408403","canonicalSmiles":"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(=O)O)C(C)C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O","inchiKey":"CZGUSIXMZVURDU-JZXHSEFVSA-N","drugType":"Protein","blackBoxWarning":false,"name":"ANGIOTENSIN II","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["5-l-isoleucineangiotensin ii","Angiotensin ii","Angiotensin ii (human type)","Angiotensin ii human","Asp-arg-val-tyr-ile-his-pro-phe","Delivert","LJPC-501"],"crossReferences":{"DailyMed":["angiotensin%20ii%20acetate"],"PubChem":["50112427"],"drugbank":["DB11842"],"chEBI":["2719"]},"childChemblIds":["CHEMBL4303682","CHEMBL3989932"],"linkedTargets":{"rows":["ENSG00000144891"],"count":1},"linkedDiseases":{"rows":["HP_0000083","EFO_0006834","EFO_0005252","EFO_0000319","HP_0031273","EFO_0000537"],"count":6},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and is indicated for cardiovascular disease and septic shock and has 4 investigational indications."}
{"id":"CHEMBL408701","canonicalSmiles":"C[C@H](CCC(=O)NCCS(=O)(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C","inchiKey":"QBYUNVOYXHFVKC-GBURMNQMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAUROLITHOCHOLIC ACID","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Taurolithocholate","Taurolithocholic acid","Tauroursodeoxycholic acid"],"crossReferences":{"chEBI":["36259"]},"childChemblIds":["CHEMBL2028239"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL417990","canonicalSmiles":"CN1CCc2cc3c(cc2[C@H]1[C@@H]1OC(=O)c2c1ccc1c2OCO1)OCO3","inchiKey":"IYGYMKDQCDOMRE-ZWKOTPCHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BICUCULLINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(+)-Bicuculline","Bicuculline"],"crossReferences":{"PubChem":["56463577"],"Wikipedia":["Bicuculline"],"drugbank":["DB11562"],"chEBI":["3092"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4204869","canonicalSmiles":"C[C@H]1OC[C@]2(c3cc(NC(=O)c4cnc(C(F)F)cn4)ccc3F)N=C(N)SC[C@H]12","inchiKey":"AACUJFVOHGRMTR-DPXNYUHVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ELENBECESTAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E-2609","E2609","Elenbecestat"],"crossReferences":{"drugbank":["DB15391"]},"linkedTargets":{"rows":["ENSG00000186318"],"count":1},"linkedDiseases":{"rows":["MONDO_0004975"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL427896","canonicalSmiles":"C[C@@H]1CN(c2ccc([N+](=O)[O-])cc2)CCN1S(=O)(=O)c1ccc(C(C)(C)C)cc1","inchiKey":"SOFGQQQVQZQJFS-MRXNPFEDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL427896","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07049"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4279521","canonicalSmiles":"Cc1nn(-c2cnc(OCC(C)C)c(Cl)c2)c2ccc(C(=O)NS(C)(=O)=O)cc12","inchiKey":"RVTSXVZXEGFIPW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-05241328","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pf-05241328"],"crossReferences":{"drugbank":["DB15124"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297274","canonicalSmiles":"CCCCCCCCCCCCNCC(O)CCCCCCCCCn1c(=O)c2c(ncn2C)n(C)c1=O","inchiKey":"MZNMZWZGUGFQJP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CT-2584","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CT 2584","Ct-2584"],"crossReferences":{"drugbank":["DB13098"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297330","canonicalSmiles":"CC(C)=CCCC(C)=CCCC(C)=CCCC1(C)CCc2cc(O)ccc2O1","inchiKey":"GJJVAFUKOBZPCB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TOCOTRIENOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alpha tocotrienol","Tocotrienol","Tocotrienol, alpha"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4297678","canonicalSmiles":"CC(O)COC[C@H]1O[C@@H]2O[C@H]3[C@H](O)[C@@H](OCC(C)O)[C@@H](O[C@@H]4[C@@H](CO)O[C@H](O[C@@H]5[C@@H](CO)O[C@H](O[C@@H]6[C@@H](COCC(C)O)O[C@H](O[C@@H]7[C@@H](CO)O[C@H](O[C@@H]8[C@@H](COCC(C)O)O[C@H](O[C@H]1C[C@H]2O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)O[C@@H]3CO","inchiKey":"NJWCVQBHNBLNOZ-ZRMYETLXSA-N","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"ADRABETADEX","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Adrabetadex","Kleptose hpb","VT-270","VTS-270","Vts-270","Vts270"],"crossReferences":{"drugbank":["DB15146"]},"description":"Oligosaccharide drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297788","drugType":"Antibody","blackBoxWarning":false,"name":"MOSUNETUZUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BTCT-4465A","BTCT4465A","Mosunetuzumab","RG-7828","RG7828","RO-7030816","RO7030816"],"linkedTargets":{"rows":["ENSG00000160654","ENSG00000167286","ENSG00000198851","ENSG00000156738"],"count":4},"linkedDiseases":{"rows":["EFO_0000096","EFO_0002690","EFO_0000095","EFO_0000403","MONDO_0018906","EFO_0005952"],"count":6},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4297863","drugType":"Antibody","blackBoxWarning":false,"name":"REMTOLUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A-1230717","ABT-122","Abt-122","Remtolumab"],"linkedTargets":{"rows":["ENSG00000232810","ENSG00000112115"],"count":2},"linkedDiseases":{"rows":["EFO_0000685","EFO_0003778"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297959","drugType":"Unknown","blackBoxWarning":false,"name":"KONJAC MANNAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E-425","Glucomannan","Ins no.425","Ins-425","Konjac","Konjac glucomannan","Konjac mannan","Konjac-flour","Konnyaku","Konnyaleu","Nutricol gp 6220","Propol phoenix 2a","Rheolex rx-h","Ticagel konjac hv","Vistop d 2134"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297972","drugType":"Unknown","blackBoxWarning":false,"name":"GWN-323","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GWN-323","GWN323","Gwn-323","Gwn323"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4298005","drugType":"Unknown","blackBoxWarning":false,"name":"MITIGLINIDE CALCIUM DIHYDRATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Glufast","KAD-1229","Kad-1229","Mitiglinide calcium dihydrate","Mitiglinide calcium hydrate","Mitiglinide calcium salt dihydrate","S-21403"],"linkedTargets":{"rows":["ENSG00000187486","ENSG00000006071"],"count":2},"linkedDiseases":{"rows":["MONDO_0005148"],"count":1},"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4301492","canonicalSmiles":"COC(=O)[C@H]1[C@@H](c2ccc(F)cc2)C[C@@H]2CC[C@H]1N2C/C=C/I","inchiKey":"GTQLIPQFXVKRKJ-UNSMHXHVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALTROPANE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Altropane","Iacft"],"crossReferences":{"drugbank":["DB04947"]},"childChemblIds":["CHEMBL4297407"],"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL4563522","canonicalSmiles":"CCCC[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(N)=O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O","inchiKey":"AVYLMJODKHVQHD-WFOXQDBGSA-N","drugType":"Protein","blackBoxWarning":false,"name":"FE 203799","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fe 203799"],"linkedTargets":{"rows":["ENSG00000065325"],"count":1},"linkedDiseases":{"rows":["EFO_0003884","MONDO_0015183"],"count":2},"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4571075","canonicalSmiles":"O=C1N[C@H](c2cncc(C#Cc3ccccc3)c2)[C@@H](c2ccccc2Cl)O1","inchiKey":"IAYVUQJOKDFLAL-NHCUHLMSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-984923","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-984923","BMS984923","Bms-984923"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594294","canonicalSmiles":"CNCC1CCCCN1C(=O)Oc1ccc(CNC(=O)CCCC/C=C/C(C)C)cc1OC","inchiKey":"BXAQOVOOXOHMFY-YRNVUSSQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VOCACAPSAICIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CA-008","Ca-008","Vocacapsaicin"],"childChemblIds":["CHEMBL4594295"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4594470","drugType":"Unknown","blackBoxWarning":false,"name":"CVX-060","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CVX-060","CVX060","Cvx-060","PF-04856884","PF04856884","Pf-04856884"],"linkedTargets":{"rows":["ENSG00000091879"],"count":1},"linkedDiseases":{"rows":["EFO_0000681","EFO_0000313","EFO_0000519"],"count":3},"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4594484","drugType":"Unknown","blackBoxWarning":false,"name":"OBI-888","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["OBI-888","Obi-888"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594531","drugType":"Unknown","blackBoxWarning":false,"name":"BI-836826","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BI 836826","BI-836826","Bi 836826","Bi-836826","Mab 37.1"],"linkedTargets":{"rows":["ENSG00000104894"],"count":1},"linkedDiseases":{"rows":["EFO_0000095","EFO_0000403","EFO_0005952"],"count":3},"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4594592","drugType":"Unknown","blackBoxWarning":false,"name":"REGN-3048","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["REGN-3048","REGN3048","Regn-3048","Regn3048"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL462019","canonicalSmiles":"O=P1(N(CCCl)CCCl)OCCCN1CCCl","inchiKey":"UMKFEPPTGMDVMI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TROFOSFAMIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A-4828","NSC-109723","Trofosfamide","Trophosphamide","Z-4828"],"crossReferences":{"PubChem":["92764496"],"Wikipedia":["Trofosfamide"],"drugbank":["DB12902"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL4650305","canonicalSmiles":"O=C(O)CCn1ccc(-c2cc(C(F)(F)F)cc(C(F)(F)F)c2)n1","inchiKey":"WSFKMLQSYRCAQE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"STG-001","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["STG-001","Stg-001"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4650353","canonicalSmiles":"Cl.N[C@@]1(c2ccccc2Cl)CCC[C@@H](O)C1=O","inchiKey":"ZQJVHBJDLMIKJK-MHDYBILJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROXYNORKETAMINE, (2R,6R)-, HYDROCHLORIDE","maximumClinicalTrialPhase":1,"parentId":"CHEMBL4650718","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(2r,6r)-hnk hydrochloride","(2r,6r)-hydroxynorketamine hydrochloride","Hydroxynorketamine, (2r,6r)-, hydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4650428","drugType":"Unknown","blackBoxWarning":false,"name":"TOLL-LIKE RECEPTOR 9","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cd_antigen: cd289","Tlr-9","Toll-like receptor 9"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4650508","drugType":"Unknown","blackBoxWarning":false,"name":"ATAMPARIB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Atamparib","RBN-2397","Rbn-2397"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4802216","drugType":"Antibody","blackBoxWarning":false,"name":"UPANOVIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SCTA-01","SCTA01","Scta01","Upanovimab"],"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL481854","canonicalSmiles":"C[C@@H]1[C@H]2C3=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]5[C@H](O)C[C@@]4(C)[C@]3(C)CC[C@@]2(C(=O)O)CC[C@H]1C","inchiKey":"PRAUVHZJPXOEIF-AOLYGAPISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MADECASSIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-88135"],"crossReferences":{"drugbank":["DB14037"],"chEBI":["73058"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL482767","canonicalSmiles":"O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1","inchiKey":"FAYAUAZLLLJJGH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SNS-314","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SNS-314","Sns 314","Sns-314"],"crossReferences":{"PubChem":["103905586","124950687"],"drugbank":["DB06134"]},"childChemblIds":["CHEMBL518051"],"linkedTargets":{"rows":["ENSG00000087586","ENSG00000178999","ENSG00000105146"],"count":3},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL49120","canonicalSmiles":"CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1","inchiKey":"IFPPYSWJNWHOLQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PD-0166285","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PD-0166285","TCMDC-140940"],"crossReferences":{"PubChem":["103905313","137275855","307078458"]},"childChemblIds":["CHEMBL3545196"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL501942","canonicalSmiles":"Oc1c(Br)cc(Oc2ccccc2)cc1Br","inchiKey":"CRSZEDOZGJPOHP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL501942","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08103"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL561540","canonicalSmiles":"O=C1/C(=N\\O)c2c(/C=C/c3ccccc3)cccc2N1Cc1cc(F)cc2c1OCOC2","inchiKey":"DDHASJXGNUWZTM-ZLEWNXFRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL561540","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08010"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL567303","canonicalSmiles":"Cc1cc(NC(=O)NCCN2CCC(O)(Cc3ccccc3)CC2)c2ccccc2n1","inchiKey":"WYJCYXOCHXWTHG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PALOSURAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Act-058362","Palosuran"],"childChemblIds":["CHEMBL1164032"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL574","canonicalSmiles":"Cc1ccc(S(N)(=O)=O)cc1","inchiKey":"LMYRWZFENFIFIT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"P-TOLUENESULFONAMIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-9908","P-methylbenzenesulfonamide","P-toluenesulfonamide","P-toluenesulfonylamide","P-tosylamide","Para-toluenesulfonamide","Paratoulene sulfonamide","Toluenesulfonamide, p-"],"crossReferences":{"PubChem":["144208792","144213814","17388752","26753007","49675005","75262"],"chEBI":["34435"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL591","canonicalSmiles":"C#CC(O)(/C=C/Cl)CC","inchiKey":"ZEHYJZXQEQOSON-AATRIKPKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHCHLORVYNOL","yearOfFirstApproval":1961,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ethchlorvynol","Placidyl"],"synonyms":["Alvinol","Arvynol","Ethchlorvynol","Ethchlorvynol civ","NSC-30372","Normoson","Nostel","Roeridorm","Serenesil","Serensil"],"crossReferences":{"Wikipedia":["Ethchlorvynol"],"drugbank":["DB00189"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1961."}
{"id":"CHEMBL61511","canonicalSmiles":"O=P1(N(CCCl)CCCl)NC(OO)CCO1","inchiKey":"VPAWVRUHMJVRHU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PERFOSFAMIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Pergamid"],"synonyms":["4-HC","4-hydroperoxycyclophosphamide","NSC-181815","Perfosfamide"],"crossReferences":{"PubChem":["124955650","144207157"],"chEBI":["196991"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL6731","canonicalSmiles":"CC(N)Cc1ccc2c(c1)OCO2","inchiKey":"NGBBVGZWCFBOGO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TENAMFETAMINE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EA-1299","Methylene dioxyamphetamine","SKF-5","Tenamfetamine"],"crossReferences":{"Wikipedia":["3,4-Methylenedioxyamphetamine"],"drugbank":["DB01509"]},"childChemblIds":["CHEMBL3186623"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL73502","canonicalSmiles":"Nc1nc2c(ncn2[C@@H]2O[C@H](CO)C[C@H]2O)c(=O)[nH]1","inchiKey":"OROIAVZITJBGSM-OBXARNEKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"3'-Deoxyguanosine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3'-Deoxyguanosine"],"crossReferences":{"drugbank":["DB03609"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL76","canonicalSmiles":"CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12","inchiKey":"WHTVZRBIWZFKQO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLOROQUINE","yearOfFirstApproval":1949,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Aralen","Chlorochine","Chloroquine","NSC-187208"],"crossReferences":{"DailyMed":["chloroquine%20phosphate"],"PubChem":["124879700","124879705","174006958","50111008","90340711"],"Wikipedia":["Chloroquine"],"drugbank":["DB00608"],"chEBI":["3638"]},"childChemblIds":["CHEMBL1326","CHEMBL58510","CHEMBL4297165","CHEMBL2095223","CHEMBL1669","CHEMBL2052012"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1949 and is indicated for malaria and has 24 investigational indications."}
{"id":"CHEMBL799","canonicalSmiles":"O=C1CCc2cc(OCCCCc3nnnn3C3CCCCC3)ccc2N1","inchiKey":"RRGUKTPIGVIEKM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CILOSTAZOL","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cilostazol","Pletal"],"synonyms":["Cilostazol","NSC-758936","OPC-13013","OPC-21"],"crossReferences":{"DailyMed":["cilostazol"],"PubChem":["104171123","11110906","11113335","124879546","144203649","170465347","174007041","26719653","26719654","26746958","26746959","50100194","50103999","50104000","56463107","85230957","855683","90341176"],"Wikipedia":["Cilostazol"],"drugbank":["DB01166"],"chEBI":["31401"]},"linkedTargets":{"rows":["ENSG00000172572"],"count":1},"linkedDiseases":{"rows":["EFO_0008493","HP_0001397","EFO_0000401","MONDO_0002679","EFO_0003876","EFO_1001145","EFO_0003914","EFO_0009562","HP_0100543","EFO_1000820","EFO_0003870","EFO_0003144","EFO_0000712","HP_0004419","EFO_0003763","EFO_0000400","HP_0002140","HP_0003124","EFO_0003875","EFO_0001645","EFO_0000556","EFO_0000319","EFO_0003843","EFO_0000713","MONDO_0021187","MONDO_0004975","Orphanet_136","EFO_0000612","MONDO_0005148","MONDO_0005178","EFO_0005672","EFO_0004265"],"count":32},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and is indicated for recurrent thrombophlebitis and has 15 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL8030","canonicalSmiles":"Cc1cccc(Oc2cnc(O)nc2)c1","inchiKey":"HJQILFPVRNHTIG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TOLIMIDONE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CP-26,154","CP-26154","MLR-1023","Mlr-1023","NSC-314335","Tolimidone"],"linkedTargets":{"rows":["ENSG00000254087"],"count":1},"linkedDiseases":{"rows":["MONDO_0005148"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL841","canonicalSmiles":"CN(C)C(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1","inchiKey":"RDOIQAHITMMDAJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"LOPERAMIDE","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Imodium","Loperamide"],"crossReferences":{"DailyMed":["loperamide%20hydrochloride"],"PubChem":["104171181","11111380","11112740","11113732","124880549","124880551","124880553","144203731","170464852","26751916","26751917","50104594","50104595","90340730"],"Wikipedia":["Loperamide"],"drugbank":["DB00836"],"chEBI":["6532"]},"childChemblIds":["CHEMBL1707"],"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003869","HP_0002014","HP_0000964","MONDO_0007254","EFO_0003929","EFO_0003843","HP_0004798","MONDO_0004565","EFO_0000305","EFO_0000311","EFO_0003060","EFO_0009130","EFO_0000304","EFO_0000512","EFO_0005611","EFO_0009523"],"count":17},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1976 and is indicated for diarrhea and has 12 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL90039","canonicalSmiles":"O=C(c1ccccc1)c1ccccc1","inchiKey":"RWCCWEUUXYIKHB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZOPHENONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Benzophenone"],"crossReferences":{"PubChem":["144207014","144209623","144210378","170465649","17389587","26752803","49816673"],"Wikipedia":["Benzophenone"],"drugbank":["DB01878"],"chEBI":["41308"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL90403","canonicalSmiles":"O=C(O)[C@@H](CS)Cc1ccccc1","inchiKey":"ZUEBVBPVXLQMQR-SECBINFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL90403","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02953"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL94081","canonicalSmiles":"C=CCOc1ccc(CC(=O)O)cc1Cl","inchiKey":"ARHWPKZXBHOEEE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALCLOFENAC","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"],"classes":["Dermatological toxicity"," Vascular toxicity"],"year":1979},"tradeNames":["Mervan"],"synonyms":["Alclofenac","W 7320"],"crossReferences":{"PubChem":["144205279","29215481"],"Wikipedia":["Alclofenac"],"drugbank":["DB13167"],"chEBI":["31183"]},"linkedTargets":{"rows":["ENSG00000095303"],"count":1},"linkedDiseases":{"rows":["EFO_0005755"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for rheumatic disease. It was withdrawn in United Kingdom  in 1979 due to Dermatological toxicity and  Vascular toxicity."}
{"id":"CHEMBL95193","canonicalSmiles":"O=C(O)C1=C[C@@H](OP(=O)(O)O)[C@@H](O)[C@H](O)C1","inchiKey":"QYOJSKGCWNAKGW-PBXRRBTRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL95193","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04328"],"chEBI":["17052"]},"childChemblIds":["CHEMBL32352"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL953","canonicalSmiles":"CCN(CC)C(=O)/C(C#N)=C/c1cc(O)c(O)c([N+](=O)[O-])c1","inchiKey":"JRURYQJSLYLRLN-BJMVGYQFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENTACAPONE","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Comtan","Comtess","Entacapone"],"synonyms":["Entacapone","Entacapone orion","Entacapone teva","OR-611"],"crossReferences":{"DailyMed":["entacapone"],"PubChem":["144205737","170464850","26757974"],"Wikipedia":["Entacapone"],"drugbank":["DB00494"],"chEBI":["4798"]},"linkedTargets":{"rows":["ENSG00000093010"],"count":1},"linkedDiseases":{"rows":["EFO_0002610","EFO_0000474","MONDO_0005180","Orphanet_44890","EFO_0004701","EFO_0001073"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and is indicated for parkinson disease and has 5 investigational indications."}
